Navneet Majhail: New blood cancer, HCT, and cell therapy program at HCA Florida Healthcare North Florida Hospital
Navneet Majhail shared on X:
“Welcome to our new blood cancer, HCT, and cell therapy program at HCA Florida Healthcare North Florida Hospital that joins Sarah Cannon Transplant and Cellular Therapy Network. Stay tuned for blood cancer clinical trial program in with Sarah Cannon Docs.”
Read further.
Source: Navneet Majhail/X
Dr. Navneet Majhail, M.D., MS, FASTCT, is a Physician-in-Chief of Blood Cancers at the Sarah Cannon Transplant and Cellular Therapy Network. He is also the program medical director at the Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center in Nashville.
His research centers on preventing and managing complications of blood and marrow transplantation, as well as health policy issues like disparities, quality of care, survivorship, and economic aspects of transplant.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023